Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Besse

Showing results (91-100 of 512) with videos related to

Pageof 52
Sort By:
Cancer Treatment Reviews|September 26, 2020
EGFR exon 20 insertions in advanced non-small cell lung cancer: A new history beginsJordi Remon, Lizza E L Hendriks, Andres F Cardona, et al.
Progress in Retinal and Eye Research|September 20, 2024
Ocular adverse events associated with antibody-drug conjugates used in cancer: Focus on pathophysiology and management strategiesEric E Gabison, Antoine Rousseau, Marc Labetoulle, et al.
Bulletin Du Cancer|March 31, 2015
[Second generation ALK inhibitors in non-small cell lung cancer: systemic review]Marie Viala, Solenn Brosseau, David Planchard, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 12, 2025
Surgical and Perioperative Advances for Patients With Locally Advanced Non-Small Cell Lung CancerAnne Opalikhin, Scott Friedland, Maria Lucia Madariaga, et al.
Bulletin Du Cancer|November 21, 2015
[Nivolumab, a new hope in non-small cell lung cancer]Ronan Flippot, Vincent Fallet, Benjamin Besse, et al.
La Revue Du Praticien|December 5, 2018
[Thymic tumors]Nicolas Girard, Claire Merveilleux Du Vignaux, Thierry Molina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
The evolving role of histology in the management of advanced non-small-cell lung cancerCorey J Langer, Benjamin Besse, Antonio Gualberto, et al.
Critical Reviews in Oncology/Hematology|June 20, 2012
Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkersStéphane Vignot, Benjamin Besse, Fabrice André, et al.
Bulletin Du Cancer|February 4, 2006
[EGFR-targeted therapies: what's new?]Stéphane Vignot, Benjamin Besse, Jean-Charles Soria, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancerArsela Prelaj, Rebecca Tay, Roberto Ferrara, et al.
Pageof 52

Showing results (91-100 of 512) with videos related to

Sort By:
Pageof 52
Cancer Treatment Reviews|September 26, 2020
EGFR exon 20 insertions in advanced non-small cell lung cancer: A new history beginsJordi Remon, Lizza E L Hendriks, Andres F Cardona, et al.
Progress in Retinal and Eye Research|September 20, 2024
Ocular adverse events associated with antibody-drug conjugates used in cancer: Focus on pathophysiology and management strategiesEric E Gabison, Antoine Rousseau, Marc Labetoulle, et al.
Bulletin Du Cancer|March 31, 2015
[Second generation ALK inhibitors in non-small cell lung cancer: systemic review]Marie Viala, Solenn Brosseau, David Planchard, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 12, 2025
Surgical and Perioperative Advances for Patients With Locally Advanced Non-Small Cell Lung CancerAnne Opalikhin, Scott Friedland, Maria Lucia Madariaga, et al.
Bulletin Du Cancer|November 21, 2015
[Nivolumab, a new hope in non-small cell lung cancer]Ronan Flippot, Vincent Fallet, Benjamin Besse, et al.
La Revue Du Praticien|December 5, 2018
[Thymic tumors]Nicolas Girard, Claire Merveilleux Du Vignaux, Thierry Molina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
The evolving role of histology in the management of advanced non-small-cell lung cancerCorey J Langer, Benjamin Besse, Antonio Gualberto, et al.
Critical Reviews in Oncology/Hematology|June 20, 2012
Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkersStéphane Vignot, Benjamin Besse, Fabrice André, et al.
Bulletin Du Cancer|February 4, 2006
[EGFR-targeted therapies: what's new?]Stéphane Vignot, Benjamin Besse, Jean-Charles Soria, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancerArsela Prelaj, Rebecca Tay, Roberto Ferrara, et al.
Pageof 52